Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 2, 2011, Pages 614-620

  Housri, Nadine ^a   Ning, Holly ^a   Ondos, John ^a   Choyke, Peter ^a   Camphausen, Kevin ^a   Citrin, Deborah ^a   Arora, Barbara ^a   Shankavaram, Uma ^a   Kaushal, Aradhana ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dose escalation; IMRT; Prostate cancer; Radiotherapy; Treatment planning

Indexed keywords

CURRENT PHASE; DOSE ESCALATION; HIGH DOSE; IMRT; INTENSITY-MODULATED RADIOTHERAPY; INTRAPROSTATIC LESIONS; LOCALIZED PROSTATE CANCER; MRI SCAN; NORMAL TISSUE; PLANNING CT; PROSTATE CANCERS; RADIATION DOSE; RADIATION THERAPY ONCOLOGY GROUPS; SIMULTANEOUS INTEGRATED BOOSTS; TOTAL DOSE; TREATMENT PLANNING;

COMPUTERIZED TOMOGRAPHY; DISEASES; PHYSICAL THERAPY; TISSUE;

RADIOTHERAPY;

ADULT; ARTICLE; BLADDER; CANCER LOCALIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RECTUM; TREATMENT OUTCOME; TREATMENT PLANNING;

HIP; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MAXIMUM TOLERATED DOSE; ORGANS AT RISK; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; URINARY BLADDER;

EID: 79955594690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.050     Document Type: Article

References (37)

1. Y.H. Shao, K. Demissie, and W. Shih Contemporary risk profile of prostate cancer in the United States J Natl Cancer Inst 101 2009 1280 1283
2. J.J. Coen, A.L. Zietman, and H. Thakral Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases J Clin Oncol 20 2002 3199 3205 (Pubitemid 34831515)
3. D.A. Kuban, A.M. el-Mahdi, and P.F. Schellhammer Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma Urology 30 1987 420 426 (Pubitemid 17163646)
4. M.J. Zelefsky, V.E. Reuter, and Z. Fuks Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer J Urol 179 2008 1368 1373 discussion 1373
5. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
6. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
7. P.A. Kupelian, J.C. Buchsbaum, and C.A. Reddy Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10) Int J Radiat Oncol Biol Phys 50 2001 621 625 (Pubitemid 32519595)
8. R. Jacob, A.L. Hanlon, and E.M. Horwitz The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer Cancer 100 2004 538 543 (Pubitemid 38124771)
9. M.J. Zelefsky, Z. Fuks, and M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881 (Pubitemid 32750970)
10. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129 (Pubitemid 351296130)
11. O. Cahlon, M.J. Zelefsky, and A. Shippy Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes Int J Radiat Oncol Biol Phys 71 2008 330 337
12. A.K. Singh, P. Guion, and N. Sears-Crouse Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: Early results of a phase I NCI study Radiat Oncol 2 2007 36
13. V. Fonteyne, G. Villeirs, and B. Speleers Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion Int J Radiat Oncol Biol Phys 72 2008 799 807
14. N. Cellini, A.G. Morganti, and G.C. Mattiucci Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning Int J Radiat Oncol Biol Phys 53 2002 595 599 (Pubitemid 34626498)
15. G. De Meerleer, G. Villeirs, and S. Bral The magnetic resonance detected intraprostatic lesion in prostate cancer: Planning and delivery of intensity-modulated radiotherapy Radiother Oncol 75 2005 325 333 (Pubitemid 41007979)
16. J. Pouliot, Y. Kim, and E. Lessard Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging Int J Radiat Oncol Biol Phys 59 2004 1196 1207 (Pubitemid 38834315)
17. S.J. DiBiase, K. Hosseinzadeh, and R.P. Gullapalli Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 52 2002 429 438 (Pubitemid 34170847)
18. M.J. Ghilezan, D.A. Jaffray, and J.H. Siewerdsen Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI) Int J Radiat Oncol Biol Phys 62 2005 406 417 (Pubitemid 40704457)
19. M. Pinkawa, M. Pursch-Lee, and B. Asadpour Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion Strahlenther Onkol 184 2008 679 685
20. K.L. Ullman, H. Ning, and R.C. Susil Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers Radiat Oncol 1 2006 2
21. J. Boda-Heggemann, F.M. Kohler, and H. Wertz Intrafraction motion of the prostate during an IMRT session: A fiducial-based 3D measurement with Cone-beam CT Radiat Oncol 3 2008 37
22. R Development Core Team. R: A language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna
23. H. Ito, K. Kamoi, and K. Yokoyama Visualization of prostate cancer using dynamic contrast-enhanced MRI: Comparison with transrectal power Doppler ultrasound Br J Radiol 76 2003 617 624
24. V.S. Khoo, A.R. Padhani, and S.F. Tanner Comparison of MRI with CT for the radiotherapy planning of prostate cancer: A feasibility study Br J Radiol 72 1999 590 597 (Pubitemid 29295033)
25. B. Pickett, E. Vigneault, and J. Kurhanewicz Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy Int J Radiat Oncol Biol Phys 44 1999 921 929 (Pubitemid 29284143)
26. P. Xia, B. Pickett, and E. Vigneault Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy Int J Radiat Oncol Biol Phys 51 2001 244 254 (Pubitemid 32758884)
27. C.M. Nutting, C.M. Corbishley, and B. Sanchez-Nieto Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy Br J Radiol 75 2002 151 161 (Pubitemid 34256461)
28. J.J. Futterer, S.W. Heijmink, and T.W. Scheenen Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449 458 (Pubitemid 44632891)
29. M. Schmuecking, C. Boltze, and H. Geyer Dynamic MRI and CAD vs. choline MRS: Where is the detection level for a lesion characterisation in prostate cancer? Int J Radiat Biol 85 2009 814 824
30. E.N. van Lin, J.J. Futterer, and S.W. Heijmink IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI Int J Radiat Oncol Biol Phys 65 2006 291 303
31. J. Haffner, E. Potiron, and S. Bouye Peripheral zone prostate cancers: Location and intraprostatic patterns of spread at histopathology Prostate 69 2009 276 282
32. J.E. McNeal, and O. Haillot Patterns of spread of adenocarcinoma in the prostate as related to cancer volume Prostate 49 2001 48 57
33. C.K. Kim, B.K. Park, and B. Kim Localization of prostate cancer using 3T MRI: Comparison of T2-weighted and dynamic contrast-enhanced imaging J Comput Assist Tomogr 30 2006 7 11 (Pubitemid 43052291)
34. L.W. Chan, P. Xia, and A.R. Gottschalk Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 69 77
35. M. Albert, J.S. Song, and D. Schultz Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate Urol Oncol 26 2008 147 152 (Pubitemid 351288564)
36. E.H. Huang, A. Pollack, and L. Levy Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321 (Pubitemid 35380030)
37. A. Harsolia, C. Vargas, and D. Yan Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study Int J Radiat Oncol Biol Phys 69 2007 1100 1109 (Pubitemid 47625853)